Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of "progression-free survival 2" as a clinical trial end-point.

ABSTRACT:

SUBMITTER: Dimopoulos MA 

PROVIDER: S-EPMC5004436 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature